Form 8-K - Current report:
SEC Accession No. 0001564590-20-005303
Filing Date
2020-02-19
Accepted
2020-02-19 16:37:23
Documents
14
Period of Report
2020-02-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20200218.htm   iXBRL 8-K 34219
2 EX-99.1 hrtx-ex991_6.htm EX-99.1 12624
3 GRAPHIC gflxm5mngevr000001.jpg GRAPHIC 23447
  Complete submission text file 0001564590-20-005303.txt   213036

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20200218.xsd EX-101.SCH 5964
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20200218_lab.xml EX-101.LAB 19480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20200218_pre.xml EX-101.PRE 11629
8 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20200218_htm.xml XML 3568
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 20630361
SIC: 2834 Pharmaceutical Preparations